Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Abroad (travel likely)RecruitingPHASE3

Conditions

Active Ankylosing Spondylitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zhanguo Li) · Zgli99@aliyun.com · 13910713924

Study leads

Zhanguo Li
Principal Investigator
Peking University People's Hospital
Xu Liu
Principal Investigator
Peking University People's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Ankylosing Spondylitis

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis

Ankylosing Spondylitis

Abroad (travel likely)RecruitingPHASE3

Beijing, China

Korean Post-marketing Surveillance for Xeljanz XR

Active Moderate to Severe Rheumatoid Arthritis · Active Ankylosing Spondylitis · Active Psoriatic Arthritis

Abroad (travel likely)Recruiting

Seoul, South Korea

The Impacts of Gluten-free Diet in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

Abroad (travel likely)Recruiting

Istanbul, Turkey (Türkiye) · Istanbul, Turkey (Türkiye)